. Glucose decay rates in young and old rats fed on a cafeteria diet (Young rats were 5 weeks old at the start of the experiment and old rats were 9-12 weeks old. Diets were provided for 3 weeks and then the rats were fasted for 5 h before receiving 400 mU insulin (Actrapid, Novo)/kg intravenously. Blood samples were obtained at 5 min intervals for glucose analysis and the fractional glucose decay rate was calculated) This possibility was further supported by the finding that the maximal activities of hexokinase and phosphofructokinase in brown adipose tissue are increased under conditions of increased thermogenesis and insulin sensitivity such as cold-acclimation (Cooney & Newsholme, 1984) , and reduced in insulin-resistant, glucose-intolerant animals such as oblob and dbldb mice , which also have defective non-shivering thermogenesis.
Further evidence was provided by the finding that a novel type of P-adrenoceptor agonist, such as BRL 26830 and BRL 35135, which interacts selectively with the atypical P-adrenoceptor in brown adipose tissue, thereby producing an anti-obesity action by stimulating thermogenesis (Arch et al. 1984) , also has antihyperglycaemic activity when dosed chronically to insulin-resistant dbldb and oblob mice (Carroll et al. 1985; Sennitt et al. 1985) . The improvement in glycaemic control in these mice is associated with increases in the maximal activities of hexokinase and phosphofructokinase, which provide a quantitative index of the maximum capacity for &coiysis (Young et al. , 1985 .
Quantitative measurement of glucose utilization
Measurements of enzyme activities in vitro only provide an indication of the maximal flux through any metabolic pathway; they do not provide a measure of the actual flux in vivo. In an attempt to quantify glucose uptake by brown adipose tissue in vivo under a variety of physiological conditions, several groups (Kraegen et al. 1983 ; F e d et al. Smith et al. 1986 ) have adopted the tracer 2-deoxyglucose technique originally used by Sokoloff et al. (1W7) for estimating glucose uptake by the brain. The use of 2-deoxyglucose as a tracer for glucose metabolism is dependent on the sugar analogue being transported from the plasma, by the specific membrane-associated glucose transporter, into the cytosol. It is phosphorylated by hexokinase to 2-deoxyglucose Gphosphate, but this is not a substrate for phosphofructokinase, and the 2-deoxyglucose &phosphate accumulates within the cell.
Measurement of plasma 2-deoxyglucose radioactivity at intervals after the intravenous injection of a bolus of 2-deoxyglucose tracer allows a disappearance curve to be constructed. This is mirrored by the accumulation of labelled 2-deoxyglucose 6-phosphate in the tissues; the whole-body accumulation curve is the sum of the individual curves of each discrete tissue. The rate of tissue glucose utilization can be calculated from the product of tissue 2-deoxyglucose 6-phosphate content and plasma glucose divided by the area under the plasma 2-deoxyglucose curve:
The inclusion of the dimensionless lumped constant (LC) is to account for the discrimination between glucose and 2-deoxyglucose by the glucose transport system and by hexokinase. Its value has been determined in a number of tissues in vitro and has been found to be between 0.6 and 1.0. Since the value of LC in vivo is unknown, and may alter under physiological conditions (Pardridge, 1983) , a value of 1.0 has been assumed in subsequent studies.
The technique is appropriate to all the peripheral glucose-consuming tissues such as muscle, adipose tissues and brain, but it is inappropriate for liver and kidney since in these tissues 2-deoxyglucose Gphosphate is dephosphorylated by glucose-6-phosphatase (Walker, 1966) . The technique allows an assessment to be made of the rate of glucose uptake by brown adipose tissue and, hence, an evaluation of both the potential
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Brown adipose tissue and nutritional energetics 209 contribution of glucose as a fuel for thermogenesis and the contribution of brown adipose tissue to the whole-body glucose-utilization rate.
Effect of thermogenic stimuli on glucose uptake by brown adipose tissue in vivo Glucose uptake by brown adipose tissue in control 06/06 mice is low, being less than 2% of the whole-body rate of glucose utilization. Both acute and chronic treatment with the thermogenic P-agonist BRL 26830 produced a significant increase in glucose uptake by brown adipose tissue and, in mice given the combined treatment, brown adipose tissue accounted for 12.5% of the whole-body rate of glucose utilization (Young et al. 1985) . This contrasts with all other tissues studied, none of which showed a significant change. This treatment with BRL 26830 results also in a very significant improvement in glucose tolerance. In addition metabolic rate is increased by 0-5-1.0 kJh. The rate of glucose uptake by brown adipose tissue (900 nmoymin per mouse) equates, if all the glucose was completely oxidized, to an increase in metabolic rate of 0.16 k J h per mouse. Thus, in this genetic mutant, it is concluded that glucose utilization by brown adipose tissue can make a substantial short-term contribution to glucose homeostasis under strong thermogenic stimulus. Furthermore, it could theoretically, if all the glucose were oxidized, be a significant fuel for thermogenesis.
To investigate the effect of insulin more directly, warm-and cold-acclimated rats were examined under euglycaemic-and either normoinsulinaemic-or hyperinsulinaemicclamp conditions (Smith et al. 1986 ).
Cold acclimation of rats at 4" for 3 weeks had no effect on the basal blood glucose concentration, but did produce a significant decrease in plasma insulin concentration. In these post-absorptive rats, under basal conditions, there were no differences in the whole-body rates of glucose production or glucose utilization between the warm-and cold-acclimated rats. However, when the plasma insulin concentration in the wannacclimated rats was raised by 50 pU/ml, glucose utilization increased by 19% and the endogenous glucose production decreased by 8%. In cold-acclimated rats, glucose utilization increased by 44% and endogenous glucose production decreased by 44%. This effect occurred in spite of the fact that the plasma insulin concentration was lower in the cold-acclimated rats than in the warm-acclimated rats ( Table 2) . The glucose metabolic indices for some key tissues are given in Table 3 . The tissue with the highest glucose metabolic index (per g wet wt) is heart. In control warmacclimated rats, the index was 284 (SD 1321) nmollmin per g. The metabolic index was increased significantly by both insulin and cold-acclimation. However, its contribution to whole-body glucose utilization was small, ranging from 2.2 to 4.7%.
Induction of physiological hyperinsulinaemia in warm-acclimated rats increased glucose utilization by some muscles (Table 3 ), but had no significant effect on brown adipose tissue. However, following cold acclimation, insulin had a highly selective effect on stimulating glucose uptake by brown adipose tissue.
In control, warm-acclimated rats the glucose metabolic index of interscapular brown adipose tissue was not significantly different from that of epididymal white adipose tissue. The basal glucose metabolic index was increased twofold in cold-acclimated rats, even though these rats had a lower plasma insulin concentration. Insulin treatment of cold-acclimated rats produced a further fourfold increase. Thus, in comparison with control warm-acclimated rats, which had similar plasma insulin concentrations (Table 2) , the glucose metabolic index of the interscapular brown adipose tissue of the coldacclimated, insulin-treated rat was increased eightfold. Under the latter conditions, the contribution of total brown adipose tissue (assuming that it all behaves like interscapular brown adipose tissue) to the whole-body glucose utilization rate is 2.3%. This is significantly more than brain and about half that of heart. Its contribution to the insulin-stimulated increase in glucose utilization in cold-acclimated rats was equivalent to that of the heart.
The contributions of brown adipose tissue to overall rates of glucose utilization in the rat are minor in comparison with muscle (1623%). However, the finding that the maximal activity of hexokinase in brown adipose tissue of cold-acclimated rats is of the order of 12 pmoYmin per g (50-to 100-fold higher than the measured rate of glucose utilization), suggests that under appropriate acute stimulation (e .g. higher concen-
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Brown adipose tissue and nutritional energetics 21 1 trations of insulin or noradrenaline, or both, or acute cold) further increases in glucose utilization are probable. It is also clear that in these cold-acclimated rats, which were studied 30 min after transfer to a warm environment, glucose utilization by brown adipose tissue makes a relatively insignificant contribution to basal and insulinstimulated metabolic rates. If all the glucose taken up by brown adipose tissue was totally oxidized to carbon dioxide then it would be equivalent to about 0.1 kJh, whereas the basal metabolic rate was 10 H/h. However, the selective increase in insulin sensitivity of brown adipose tissue relative to other tissues (Table 3) suggests that insulin-mediated processes are important in maintaining the capacity for increased non-shivering thermogenesis.
The glucose flux through brown adipose tissue and other major sites of glucose utilization has also been quantified in rats exhibiting high rates of thermogenesis. Since the techniques for quantifymg these fluxes demand steady-state conditions, we have used the long-acting selective kadrenoceptor agonist BRL 26830, rather than noradrenaline, to increase metabolic rate (Cawthome er al. 1987). Acute treatment with BRL 26830 (5 mgkg intraperitoneally) produced a small reduction in the steady-state glucose concentrations (6.0 (SD 0.4) v. 5.1 (SD 0.2) mM for control and treated rats respectively PCO.01). However, whole-body glucose utilization was not increased significantly (19.3 (SD 1.5) v . 20.4 (SD 1.8) FmoYmin), although the metabolic clearance rate of glucose was significantly increased (32.3 (SD 2.2) v. 40-5 (SD 4-3) mumin per kg, P<O-Ol). The effect of treatment with a thermogenic f3-agonist on tissue rates of glucose utilization is shown in Table 4 . Glucose utilization in brown adipose tissue was increased fifteenfold, but was nevertheless only a small (4%) component of the overall glucose utilization.
This conclusion is further supported by recent work by Ma & Foster (1986) who measured directly from arterio-venous difference and blood flow determinations glucose uptake by brown adipose tissue of cold-acclimated rats in which thermogenesis was stimulated by an infusion of noradrenaline. The basal glucose uptake rate of brown adipose tissue was similar using the arterio-venous difference and 2-deoxyglucose technique. Noradrenaline infusion produced an eightyfold increase in glucose uptake. This was accompanied by increases in the output of lactate and pyruvate such that the contribution of glucose oxidation to thermogenesis at the maximal stimulatory dose of noradrenaline is only 2%. Furthermore, even an eightyfold increase in glucose utilization by brown adipose tissue had little overall effect on whole-body rates of glucose utilization.
All these studies show that conditions that increase energy expenditure via a stimulation of brown adipose tissue also produce an increase in glucose utilization by brown adipose tissue. Furthermore, conditions that lead to an increase in thermogenic capacity also result in a selective increase in the insulin sensitivity of brown adipose tissue. Even though brown adipose tissue glucose uptake and oxidation cannot make a significant contribution to the thermogenic fuel, it is likely that glucose utilization by brown adipose tissue is critically important in the generation of the thermic response. It is suggested that the insulin-mediated glucose uptake is anaplerotic to maintain pools of glycolytic and citric acid cycle intermediates as well as providing a source of glycerol phosphate for free fatty acid esterification and triglyceride synthesis.
Decreased glucose utilization in brown adipose tissue and the development of impaired glucose tolerance Although studies on glucose utilization in animals given thermogenic stimuli do not in general support the idea that the brown adipose tissue makes a significant contribution to glucose homeostasis, the possibility still exists that defective glucose utilization in brown adipose tissue in insulin-resistant models might account for the development of diabetes. Indeed, a number of animal models do demonstrate an early development of an insulin-resistant state in brown adipose tissue. However, quantitative studies on wholebody and tissue glucose utilization rates, using physiological concentrations of insulin in rats fed on a high-fat diet Kraegen et al. 1986 ), show that brown adipose tissue cannot account for the fall. in whole-body rates of glucose utilization. Similar conclusions can be drawn from studies on lactating rats and obese Zucker rats (FerrC et al. 1986 ).
Insulin resistance in brown adipose tissue
A large number of studies have shown that rodent models of diabesity exhibit an early hyperinsulinaemia followed by insulin resistance. In addition it is now becoming evident that insulin resistance does not develop coincidentally in all tissues, and temporarily occurs earliest in brown adipose tissue. Furthermore, of all the tissues in rodents, brown adipose tissue shows the largest increase in responsiveness with respect to physiological changes in the insulin concentration. These findings lead to the hypothesis that the early hyperinsulinaemia, coupled with the high responsiveness of brown adipose tissue to insulin in pre-obese animals, leads to an over-supply of glucose in relation to its needs. The development of insulin resistance in brown adipose tissue may be an important protective mechanism to prevent a continual over-supply of glucose, which will be stored as glycogen and triacylglyceride. If a high rate of glucose utilization is essential for expression of a normal thermic response (to cold or food), then this insulin resistance might be a causal factor in the development of obesity. If such suggestions are correct then one might expect agents that improve insulin sensitivity in animals to restore thermogenic activity in situations in which it is defective.
Mercer & Trayhurn (1984) showed that a loss of thermogenic responsiveness to cold in oblob mice developed between 26 and 35 d of age. This coincided with the development of insulin resistance as determined by alterations in the stimulation by insulin of lipogenesis. Treatment of oblob mice with a compound called ciglitazone, which improves diabetic control in a range of animal models (Chang et al. 1983a, b,c) , not only restored insulin sensitivity, but also restored the ability of cold to acutely increase GDP binding to brown adipose tissue mitochondria, which is believed to be an index of thermogenic activity (Mercer & Trayhurn, 1986) . In other studies, Thurlby et al. (1987) found that chronic treatment of normal adult mice with ciglitazone increased the amount of brown adipose tissue mitochondria1 protein and total GDP binding very significantly. Furthermore, whilst having no stimulatory effect itself on the metabolic rate of the mice, it allowed a significant enhancement of the thermogenic response to the f3- Ciglitazone and a number of agents that improve insulin sensitivity also produce brown adipose tissue hypertrophy (Thurlby et al. 1987; Sohda et al. 1982) . This suggests that the synthesis or degradation, or both, of brown adipose tissue proteins, including the 32kDa uncoupling protein, might be regulated also by insulin.
Brown adipose tissue in man
In humans the role of BAT as an effector of non-shivering thermogenesis has not been clearly established, and it is possible that muscle is the principal effector. Nevertheless, there is now evidence that normal sensitivity to insulin is required for thermogenesis following either a glucose lead or a mixed meal. Thus, older subjects have a reduced thermogenic i'esponse to glucose relative to young subjects (Golay et al. 1983) , and there is a reduced response in both obese and diabetic subjects in relation to the degree of glucose intolerance (Golay et al. 1982) . The possibility that these reduced responses are related to insulin sensitivity rather than the plasma insulin concentration has recently been confirmed in similar groups of obese and diabetic patients by the demonstration of a correlation between rate of glucose uptake and net change in energy expenditure under euglycaemic-insulin-clamp conditions (Golay et al. 1986) .
The normal thermogenic response to a meal of glucose in man is 10% of the energy content of the meal and, therefore, differences in the thermogenic response between normal and insulin-resistant subjects are small. Nevertheless, the cumulative effect of such a difference in energy expenditure could have an influence on the development of human obesity as it does in rodents.
Conclusions and speculations
(1) Brown adipose tissue glucose metabolism is modified selectively by insulin according to the physiological status of the animal: impaired in insulin-resistant animals, and increased in insulin-sensitive animals.
(2) Noradrenaline and thermogenic P-agonists stimulate glucose uptake by brown adipose tissue.
(3) Increased glucose uptake by brown adipose tissue supports thermogenesis but glucose is not a major fuel (with the possible exception of oblob mice given f3-agonists).
(4) Glucose utilization by brown adipose tissue is probably not important in the direct regulation of blood glucose concentrations.
(5) Changes in insulin sensitivity of brown adipose tissue may modulate the ability to activate thermogenesis both through short-term effects on glucose flux into brown adipose tissue and through longer-term effects on the amount of mitochondria1 proteins, particularly uncoupling protein. Thus, the development of insulin resistance may be a fundamental defect in the development of obesity as well as in diabetes.
